Aussie mining’s next takeover targets
M&A in the ASX mining space has gone ballistic. Fundie Rusty Delroy says these three juniors shape as logical takeover targets.
Stockhead
Locksley raises $1.4m for Mojave driling
On the charge to a daily high of 7.1c was Locksley Resources, after raising $1.47m in a placement.
ASX falls as investors take profits on banking stocks
The ASX has fallen 0.13pc today, after a sell-down in banking stocks and weakness in materials undercut the Energy sector’s gains.
Fisher & Paykel Healthcare reports record revenue
The Kiwi medical devices outfit has upped its full year revenue to a record $2.2 billion and guides to a stronger result this year
More Stories
A new mineral sands hotspot in Sri Lanka
With major regulatory hurdles cleared, production is within reach at Titanium Sands’ Mannar Island project.
ATC advances silicon in batteries tech
Altech’s latest Silumina Anode technological breakthrough has delivered a 50% capacity improvement in battery applications.
BTR US$11.5m working capital facility to advance gold production
Brightstar Resources has executed a working capital facility with Ocean Partners Australia to boost CY25 production and accelerate exploration.
NTI164 shows strong safety in tox tests
Neurotech clears key safety hurdle for NTI164, paving the way for longer studies and global filings.
EBR applies for cardiac device outpatient reimbursement
Having already received a recommendation for inpatients from the CMS, EBR is now applying for reimbursement for its WISE CRT System for outpatients under the same criteria.
KNG starts Leliyn scoping study
Kingsland’s scoping study for Leliyn will be underpinned by the initial indicated resource of 1Mt contained graphite.
WCN looks to maiden copper resource at Rae project
White Cliff Minerals has reported up to 4.46% copper from RC drilling at its Rae project in Canada, with results to inform a maiden resource estimate.
Uranium rebound? Five reasons it could happen
Uranium prices are showing renewed signs of life. Which juniors have the most leverage if the comeback goes nuclear?
Trump powers copper dream
Copper explorers in the United States are toasting the best regulatory conditions they’ve seen in years in the early days of Trump 2.0.
Neurizon trial reveals heightened ALS survival rate
Neurizon’s NUZ-001 treatment has demonstrated increased survival in patients with ALS, reducing risk of death by 78.5pc.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/64